Across TCGA pan-cancer cohorts, FAT1P1 RNA is linked to patient survival in 4 of 34 cancer types, making it the most broadly survival-associated FAT1P1 data layer.

The strongest signal is observed in liver hepatocellular carcinoma (LIHC), where higher FAT1P1 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated FAT1P1 expression acts as an unfavorable survival marker, although some lineages such as SKCM and COAD show a favorable association.

LIHC, SKCM, and BLCA are the cancer types where FAT1P1 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LIHC	DFS	Tertile	III,IV	0.076	0.360	.001	63	view →
SKCM	OS	Tertile	II,III,IV	1.000	0.833	.035	12	view →
BLCA	DFS	Tertile	III,IV	0.144	0.498	.002	9	view →
COAD	DFS	Tertile	All	1.000	0.774	.024	6	view →

Pink = unfavorable, green = favorable. Showing the 4 strongest of 4 lineages.

Exploration

Same gene, other analysis: FAT1P1 tumor-vs-normal RNA expression · all FAT1P1 data types